NCT05123079View on ClinicalTrials.gov

Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

November 21, 2021

Study Completion Date

December 7, 2021

Conditions
Healthy
Interventions
DRUG

Darigabat

Tablets

Trial Locations (1)

85283

Celerion Inc., Tempe

Sponsors
All Listed Sponsors
lead

Cerevel Therapeutics, LLC

INDUSTRY

NCT05123079 - Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants | Biotech Hunter | Biotech Hunter